| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |